Anogenital human papillomavirus virus DNA and sustained response to the quadrivalent HPV vaccine in women living with HIV-1

about

Anogenital human papillomavirus virus DNA and sustained response to the quadrivalent HPV vaccine in women living with HIV-1

Item

http://www.wikidata.org/entity/Q58772965

description

article

@en

wetenschappelijk artikel

@nl

наукова стаття, опублікована в серпні 2018

@uk

name

Anogenital human papillomaviru ...... ine in women living with HIV-1

@en

Anogenital human papillomaviru ...... ine in women living with HIV-1

@nl

type

Item

label

Anogenital human papillomaviru ...... ine in women living with HIV-1

@en

Anogenital human papillomaviru ...... ine in women living with HIV-1

@nl

prefLabel

Anogenital human papillomaviru ...... ine in women living with HIV-1

@en

Anogenital human papillomaviru ...... ine in women living with HIV-1

@nl

P1476

Anogenital human papillomaviru ...... ine in women living with HIV-1

@en

P2093

Alfred Saah

http://www.w3.org/2001/XMLSchema#string

Catherine Godfrey

http://www.w3.org/2001/XMLSchema#string

Erna Milunka Kojic

http://www.w3.org/2001/XMLSchema#string

Jennifer Y Webster-Cyriaque

http://www.w3.org/2001/XMLSchema#string

Judith A Aberg

http://www.w3.org/2001/XMLSchema#string

Michelle S Cespedes

http://www.w3.org/2001/XMLSchema#string

Minhee Kang

http://www.w3.org/2001/XMLSchema#string

Reena Masih

http://www.w3.org/2001/XMLSchema#string

Susan Cu-Uvin

http://www.w3.org/2001/XMLSchema#string

Triin Umbleja

http://www.w3.org/2001/XMLSchema#string

P2860

Quadrivalent vaccine against human papillomavirus to prevent high-grade cervical lesions

Anal dysplasia in HIV-infected women: a commentary on the field.

The high prevalence of HPV and HPV16 European variants in cervical and anal samples of HIV-seropositive women with normal Pap test results.

Carcinogenicity of Human Papillomavirus (HPV) Types in HIV-Positive Women: A Meta-Analysis From HPV Infection to Cervical Cancer.

Cancer risk in the Swiss HIV Cohort Study: associations with immunodeficiency, smoking, and highly active antiretroviral therapy.

Quadrivalent vaccine against human papillomavirus to prevent anogenital diseases.

Risk of anal cancer in HIV-infected and HIV-uninfected individuals in North America

Immunogenicity and safety of the quadrivalent human papillomavirus vaccine in HIV-1-infected women.

Safety and immunogenicity of the quadrivalent human papillomavirus vaccine in HIV-1-infected men

Comparison of long-term immunogenicity and safety of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine and HPV-6/11/16/18 vaccine in healthy women aged 18-45 years: end-of-study analysis of a Phase III randomized trial.

P304

15-21

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.PVR.2018.08.002

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

http://www.w3.org/2001/XMLSchema#string

P50

Beatriz Grinsztejn

Cynthia Firnhaber

P577

2018-08-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30118852

http://www.w3.org/2001/XMLSchema#string

P932

6121154

http://www.w3.org/2001/XMLSchema#string